View Comments
LAFAYETTE, Ind. Wabash Township Trustee Jennifer Teising doesn t want to be judged or tried in Tippecanoe County on 20 felony charges that she stole taxpayer money.
During the first-term Democratic trustee s initial hearing, Teising s attorney, Karen Celestino-Horseman, said she plans to file motions for a change of venue, a change of judge and a change of prosecutors.
A grand jury indicted Teising on May 12, accusing her of theft for taking her trustee salary between June and March while she was not living in the township, as required by law.
Celestino-Horseman waived the reading of the charges against Teising, making the hearing a short one.
City Councilor calls for Jennifer Teising s resignation, Teising planning to sue prosecutor
West Lafayette City Councilman James Blanco is calling for Wabash Township Trustee Jennifer Teising s resignation. Teising says she is looking to take legal action against the county prosecutor.
Posted: May 17, 2021 1:58 PM
Updated: May 17, 2021 2:39 PM
Posted By: Anna Darling
WEST LAFAYETTE, Ind. (WLFI) - West Lafayette At-Large City Councilman James Blanco is calling for Wabash Township Trustee Jennifer Teising s resignation. Trustee Teising said she is looking to take legal action against the Tippecanoe County Prosecutor.
In a written statement sent to News 18, Councilman Blanco said he has witnessed controversy after controversy concerning increasingly erratic and harmful behavior of Trustee Teising.
Pfizer-BioNTech COVID-19 vaccine effective in patients with myeloproliferative neoplasms
Researchers in the UK have provided evidence that Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine induces effective immune responses in patients with myeloproliferative neoplasms.
The team from Guy’s & St Thomas’ NHS Foundation Trust in London and King’s College London say the findings are reassuring, given that concerns have arisen regarding the efficacy of such vaccines in immunosuppressed individuals, including those with hematological malignancy.
“Myeloproliferative neoplasms (MPN), in particular myelofibrosis (MF), are associated with heterogeneous immune defects which are influenced by patient age, disease subtype, and the use of cytoreductive therapies,” write the researchers.